ENTITY
Bloomage Biotechnology  Lt

Bloomage Biotechnology Lt (688363 CH)

91
Analysis
Health Care • China
Bloomage Biotechnology Corporation Limited develops and manufactures medical products. The Company produces fillers, mesotherapy products, bio reactive hyaluronic acids, repair soothing skin care products, and other products. Bloomage Biotechnology supplies its products in medicine, cosmetics, food manufacturing companies, medical institutions, and other fields.
more
Exchange Announcement • 02 Apr 2021 16:06

Huaxi Biological Announcement on Convening the 2020 Annual Performance Briefing Meeting (华熙生物关于召开2020年度业绩说明会的公告)

Exchange Announcement • 19 Feb 2021 18:37

Independent Opinions Of Independent Directors Of Huaxi Biotechnology Co., Ltd. On Relevant Proposals Of The 20th Meeting Of The First Board Of Directors (华熙生物科技股份有限公司独立董事关于第一届董事会第二十次会议相关议案的独立意见)

Exchange Announcement • 10 Feb 2021 16:06

Huaxi Biotech'S Reminder Announcement On Shareholders Holding More Than 5% Of Shares Reduced By More Than 1% (华熙生物关于持股5%以上股东减持超过1%的提示性公告)

Exchange Announcement • 03 Feb 2021 18:21

Huaxi Biotechnology Co., Ltd. 2021 Restricted Stock Incentive Plan (华熙生物科技股份有限公司2021年限制性股票激励计划)

Exchange Announcement • 24 Jan 2021 16:47

Huaxi Biological Voluntary Announcement On Food Business (华熙生物关于食品业务的自愿性公告)

x